SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Synthetic Genomics, Inc. announced today that the company has entered into a collaboration with Ceva Santé Animale to utilize Synthetic Genomics' next ...

The aim of the Center for Synthetic Genomics is to spark new developments in synthetic genomics through basic research and technology development using methods of artificial intelligence.

SAN DIEGO, June 1, 2017 /PRNewswire/ -- Synthetic Genomics, Inc. and Advaxis, Inc. (NASDAQ:ADXS) announced today that they have completed development and deployment of the first current good ...

Yesterday BNET's Kirsten Korosec covered a new $600 million deal by ExxonMobil to develop biofuels using algae, an uncharacteristic move for a company that has often scoffed at renewable energy.

Digital-to-biological converter from Synthetic Genomics uses electronic information to synthesize biological molecules, including drugs, vaccines and virus particles. News. Local. Sports.

Synthetic Genomics, Inc., a privately held biotechnology company, announced that it will begin operating under its new corporate name, Viridos, Inc., ...

A shortcut for testing the viability of synthetic gene variants has been published by researchers at the J. Craig Venter Institute and Synthetic Genomics Inc. Related . Craig Venter Institute unvei… ...